These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 30548945

  • 1. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
    Krell A, Wolter M, Stojcheva N, Hertler C, Liesenberg F, Zapatka M, Weller M, Malzkorn B, Reifenberger G.
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
    [Abstract] [Full Text] [Related]

  • 2. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S, Zeng A, Hu Q, Yan W, Liu Y, You Y.
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression.
    Jiang C, Shen F, Du J, Fang X, Li X, Su J, Wang X, Huang X, Liu Z.
    Biomed Pharmacother; 2018 Jan; 97():844-850. PubMed ID: 29136760
    [Abstract] [Full Text] [Related]

  • 4. Role of microRNAs Located on Chromosome Arm 10q in Malignant Gliomas.
    Wolter M, Werner T, Malzkorn B, Reifenberger G.
    Brain Pathol; 2016 May; 26(3):344-58. PubMed ID: 26223576
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
    Chen HS, Lu AQ, Yang PY, Liang J, Wei Y, Shang YW, Li Q.
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
    [Abstract] [Full Text] [Related]

  • 6. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J, Xu J, Li H, Sun C, Yu L, Li Y, Shi C, Zhou X, Bian X, Ping Y, Wen Y, Zhao S, Xu H, Ren L, An T, Wang Q, Yu S.
    Oncotarget; 2015 Oct 06; 6(30):29129-42. PubMed ID: 26320176
    [Abstract] [Full Text] [Related]

  • 7. Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.
    Wang C, Chen Q, Li S, Li S, Zhao Z, Gao H, Wang X, Li B, Zhang W, Yuan Y, Ming L, He H, Tao B, Zhong J.
    Oncotarget; 2017 Feb 07; 8(6):10287-10297. PubMed ID: 28055966
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
    Ma S, Fu T, Zhao S, Gao M.
    Eur J Pharmacol; 2019 Jun 05; 852():42-50. PubMed ID: 30851271
    [Abstract] [Full Text] [Related]

  • 9. MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial-mesenchymal transitions of human glioma cells.
    Li Z, Qian R, Zhang J, Shi X.
    Biosci Rep; 2019 Mar 29; 39(3):. PubMed ID: 30314994
    [Abstract] [Full Text] [Related]

  • 10. Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.
    Nix JS, Yuan M, Imada EL, Ames H, Marchionni L, Gutmann DH, Rodriguez FJ.
    Neuropathol Appl Neurobiol; 2021 Feb 29; 47(1):96-107. PubMed ID: 32603552
    [Abstract] [Full Text] [Related]

  • 11. Suppression of long non-coding RNA PCAT19 inhibits glioma cell proliferation and invasion, and increases cell apoptosis through regulation of MELK targeted by miR-142-5p.
    Xie YH, Hu J.
    Genes Genomics; 2020 Nov 29; 42(11):1299-1310. PubMed ID: 32980991
    [Abstract] [Full Text] [Related]

  • 12. MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas.
    Qian J, Li R, Wang YY, Shi Y, Luan WK, Tao T, Zhang JX, Xu YC, You YP.
    Mol Cell Biochem; 2015 May 29; 403(1-2):33-41. PubMed ID: 25648114
    [Abstract] [Full Text] [Related]

  • 13. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
    Han J, Chen Q.
    Int J Clin Exp Pathol; 2015 May 29; 8(10):12698-707. PubMed ID: 26722459
    [Abstract] [Full Text] [Related]

  • 14. miR-152-5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7.
    Kong S, Fang Y, Wang B, Cao Y, He R, Zhao Z.
    J Cell Mol Med; 2020 Apr 29; 24(8):4569-4579. PubMed ID: 32150671
    [Abstract] [Full Text] [Related]

  • 15. An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 pathway.
    Wang M, Yang C, Liu X, Zheng J, Xue Y, Ruan X, Shen S, Wang D, Li Z, Cai H, Liu Y.
    J Cell Mol Med; 2020 Jun 29; 24(11):6120-6136. PubMed ID: 32368853
    [Abstract] [Full Text] [Related]

  • 16. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A, Romeo SG, Cama A, La Torre D, Barresi V, Pezzino G, Tomasello C, Cardali S, Angileri FF, Polito F, Ferlazzo G, Di Giorgio R, Germanò A, Aguennouz M.
    Tumour Biol; 2016 Oct 29; 37(10):14035-14048. PubMed ID: 27495233
    [Abstract] [Full Text] [Related]

  • 17. miR-23b-5p promotes the chemosensitivity of temozolomide via negatively regulating TLR4 in glioma.
    Gao K, Wang T, Qiao Y, Cui B.
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul 28; 53(8):979-987. PubMed ID: 34110366
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1.
    Ma XL, Shang F, Ni W, Zhu J, Luo B, Zhang YQ.
    J Cancer Res Clin Oncol; 2018 Dec 28; 144(12):2351-2366. PubMed ID: 30225541
    [Abstract] [Full Text] [Related]

  • 19. Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p.
    Hua L, Huang L, Zhang X, Feng H, Shen B.
    Neuroreport; 2019 Dec 18; 30(18):1231-1238. PubMed ID: 31599823
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms for hypoxia-induced long non-coding small nucleolar RNA host gene 14 in promoting temozolomide resistance of glioma.
    Zhao H, Meng L, Liao X, Liu Y, Mo X, Gong M, Liao Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul 28; 47(7):829-838. PubMed ID: 36039578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.